Loading clinical trials...
Loading clinical trials...
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Conditions
Interventions
Ingenol Mebutate (Picato®)
Generic Ingenol Mebutate
+1 more
Locations
22
United States
Center for Dermatology Clinical Research, Inc
Fremont, California, United States
SD Sports Medicine & Family Health Center
San Diego, California, United States
The Center for Clinical and Cosmetic Research
Aventura, Florida, United States
Savin Medical Group Research Center
Miami Lakes, Florida, United States
Tory P. Sullivan, M.D., P.A.
North Miami Beach, Florida, United States
Moore Clinical Research, Inc.
Tampa, Florida, United States
Start Date
February 1, 2015
Primary Completion Date
September 1, 2015
Completion Date
September 1, 2015
Last Updated
May 12, 2020
NCT07340697
NCT06778434
NCT07137819
NCT06648447
NCT05688904
NCT07286318
Lead Sponsor
Actavis Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions